Background illustration for clinical trials search

Paid Clinical Trials Denton

Discover 1,918 paid clinical trials in Denton, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of ASP1002 in Adults for Treatment of Solid Tumors

for
Advanced Solid Tumors
Location: Dallas TX, Iowa City IA, Louisville KY, Saint Paul MN,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT05719558

Phase1, Recruiting

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

for
High Grade Epithelial Ovarian Cancer,
Location: Dallas TX, Fort Worth TX, Tyler TX, Oklahoma City OK,
Sponsor: Genmab

Sex: All

Age: 18+

Code: NCT05579366

Phase1, Phase2, Recruiting

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

for
Advanced Solid Tumor, Unresectable Solid Tumor,
Location: Dallas TX, Houston TX, Nashville TN, Lexington KY,
Sponsor: Clasp Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06778863

Phase1, Recruiting

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

for
NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer,
Location: Dallas TX, Austin TX, The Woodlands TX, Houston TX,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06881784

Phase3, Recruiting

Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors

for
Advanced Cancer, Metastatic Cancer
Location: Dallas TX, Rochester MN, Chicago IL, Phoenix AZ,
Sponsor: Qurient Co., Ltd.

Sex: All

Age: 18+

Code: NCT05394103

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Dallas TX, San Antonio TX, Fairway KS, Louisville KY,
Sponsor: Impact Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04768868

Phase1, Recruiting

JAB-2485 Activity in Adult Patients With Advanced Solid Tumors

for
Solid Tumors, ER+ Breast Cancer,
Location: Dallas TX, St Louis MO, Salt Lake City UT, Detroit MI
Sponsor: Jacobio Pharmaceuticals Co., Ltd.

Sex: All

Age: 18+

Code: NCT05490472

Phase1, Phase2, Recruiting

First in Human Study of UCT-03-008 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Dallas TX, Los Angeles CA
Sponsor: 1200 Pharma, LLC

Sex: All

Age: 18+

Code: NCT05103046

Phase1, Recruiting

SW-682 in Advanced Solid Tumors

for
Advanced Solid Tumor, Mesothelioma, Malignant
Location: Dallas TX, Houston TX, Scottsdale AZ, Cleveland OH,
Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany

Sex: All

Age: 18+

Code: NCT06251310

Phase1, Recruiting

BP1001-A in Patients With Advanced or Recurrent Solid Tumors

for
Solid Tumor, Adult, Carcinoma, Ovarian Epithelial,
Location: Dallas TX, Houston TX, Detroit MI, Silver Spring MD
Sponsor: Bio-Path Holdings, Inc.

Sex: All

Age: 18+

Code: NCT04196257

Phase1, Recruiting

Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone

for
Carcinoma, Squamous Cell
Location: Dallas TX, Houston TX, Little Rock AR, Aurora CO,
Sponsor: Introgen Therapeutics

Sex: All

Age: 18+

Code: NCT00041626

Phase3, Recruiting

Asciminib Roll-over Study

for
Chronic Myelogenous Leukemia,
Location: Dallas TX, Houston TX, Milwaukee WI, Ann Arbor MI,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 7 - 70+

Code: NCT04877522

Recruiting

Study of STP938 (Dencatistat) in Advanced Solid Tumours

for
Solid Tumor
Location: Dallas TX, San Antonio TX, St. Petersburg FL
Sponsor: Step Pharma, SAS

Sex: All

Age: 18+

Code: NCT06297525

Phase1, Recruiting

Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Dallas TX, Houston TX, San Antonio TX, Nashville TN,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT05007782

Phase1, Recruiting

Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer

for
Advanced HR+/HER2- Breast Cancer
Location: Dallas TX, Toronto, New Haven CT
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07604571

Phase1, Recruiting

Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer

for
Prostate Cancer,
Location: Dallas TX, St Louis MO, Nashville TN, Greenville SC,
Sponsor: Janux Therapeutics

Sex: Male

Age: 18+

Code: NCT07545811

Phase1, Recruiting

A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.

for
TP53 Y220C Mutation, Advanced Solid Tumors
Location: Dallas TX, San Antonio TX, Denver CO, Nashville TN,
Sponsor: PMV Pharmaceuticals, Inc

Sex: All

Age: 18+

Code: NCT07372625

Phase1, Recruiting

A Study of NEOK002, an EGFR and MUC1 Targeting Bispecific ADC, in Participants With Select Solid Tumors

for
Locally Advanced (Unresectable) or Metastatic Solid Tumors
Location: Dallas TX, Austin TX, Houston TX, San Antonio TX,
Sponsor: NEOK Bio, Inc.

Sex: All

Age: 18+

Code: NCT07612189

Phase1, Recruiting

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

for
Prostate Cancer
Location: Dallas TX, San Antonio TX, Kansas City KS, Metairie LA,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT06780670

Phase2, Phase3, Recruiting

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

for
Somatostatin Receptor Positive (SSTR+),
Location: Dallas TX, Fayetteville AR, New Orleans LA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 12 - 70+

Code: NCT06784752

Phase3, Recruiting